We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAN icon
351
ManpowerGroup
MAN
$2.6B
$5.33M 0.03%
54,787
-86,481
-61% -$8.68M
AVY icon
352
Avery Dennison
AVY
$12.8B
$5.3M 0.03%
24,466
-6,875
-22% -$1.47M
CBRE icon
353
CBRE Group
CBRE
$43.3B
$5.28M 0.03%
48,676
-117,097
-71% -$12M
CME icon
354
CME Group
CME
$95.4B
$5.27M 0.03%
23,049
-1,782
-7% -$392K
SRE icon
355
Sempra
SRE
$58.1B
$5.24M 0.03%
79,270
-196
-0.2% -$12.4K
PRU icon
356
Prudential Financial
PRU
$42.6B
$5.11M 0.03%
47,250
-6,034
-11% -$655K
TFC icon
357
Truist Financial
TFC
$63.9B
$5.07M 0.03%
86,543
-4,672
-5% -$285K
DOW icon
358
Dow Inc
DOW
$22B
$5.06M 0.03%
89,263
+7,572
+9% +$432K
MAS icon
359
Masco
MAS
$14.3B
$5.05M 0.03%
71,852
-148,343
-67% -$9.6M
PSNL icon
360
Personalis
PSNL
$1.25B
$5.03M 0.03%
352,500
+10,633
+3% +$177K
DFS
361
DELISTED
Discover Financial Services
DFS
$5.02M 0.03%
43,462
+4,409
+11% +$522K
BRKR icon
362
Bruker
BRKR
$9.4B
$4.96M 0.03%
59,128
-3,000
-5% -$240K
URI icon
363
United Rentals
URI
$65.7B
$4.95M 0.03%
14,884
-3,854
-21% -$1.37M
GIS icon
364
General Mills
GIS
$20.2B
$4.83M 0.03%
71,673
-44,743
-38% -$2.84M
FOE
365
DELISTED
Ferro Corporation
FOE
$4.79M 0.03%
219,249
+95,586
+77% +$2.03M
DTIL icon
366
Precision BioSciences
DTIL
$178M
$4.68M 0.03%
21,105
AOS icon
367
A.O. Smith
AOS
$8.55B
$4.63M 0.03%
53,990
+13,719
+34% +$1.05M
TSCO icon
368
Tractor Supply
TSCO
$16.3B
$4.59M 0.03%
96,245
+3,260
+4% +$143K
NTRS icon
369
Northern Trust
NTRS
$21.8B
$4.55M 0.03%
38,062
-2,739
-7% -$328K
QSR icon
370
Restaurant Brands International
QSR
$26.2B
$4.53M 0.03%
74,644
+255
+0.3% +$15K
REG icon
371
Regency Centers
REG
$14.9B
$4.53M 0.03%
+60,110
New +$4.34M
KRA
372
DELISTED
Kraton Corporation
KRA
$4.47M 0.03%
96,608
+46,756
+94% +$2.15M
BX icon
373
Blackstone
BX
$104B
$4.41M 0.03%
34,063
-1,680
-5% -$224K
ED icon
374
Consolidated Edison
ED
$41.4B
$4.39M 0.03%
51,459
+3,817
+8% +$300K
EWC icon
375
iShares MSCI Canada ETF
EWC
$6.12B
$4.36M 0.03%
113,314

Similar funds

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.